Endoprosthetic Use in Pediatric and Adolescent Lower Limb Sarcoma Treatment.
1/5 보강
Endoprosthetic reconstruction has revolutionized the treatment of pediatric and adolescent lower limb sarcoma.
APA
Morrison SG, Binite OT, Donnan LT (2026). Endoprosthetic Use in Pediatric and Adolescent Lower Limb Sarcoma Treatment.. The Journal of the American Academy of Orthopaedic Surgeons, 34(5), e636-e647. https://doi.org/10.5435/JAAOS-D-25-00214
MLA
Morrison SG, et al.. "Endoprosthetic Use in Pediatric and Adolescent Lower Limb Sarcoma Treatment.." The Journal of the American Academy of Orthopaedic Surgeons, vol. 34, no. 5, 2026, pp. e636-e647.
PMID
41144857 ↗
Abstract 한글 요약
Endoprosthetic reconstruction has revolutionized the treatment of pediatric and adolescent lower limb sarcoma. These malignancies commonly affect the knee region, the site of the most actively growing physes of the lower limb. Modular and expandable endoprostheses have addressed the challenge of limb length discrepancy following physeal resection, with newer designs allowing noninvasive lengthening. However, decision making in pediatric tumor patients is complex, particularly given the potential number of reconstructive options, necessitating shared decision making between surgeons, patients, and families. The goal of surgery in achieving an R0 resection is nonnegotiable; reconstruction follows this. Endoprosthetic planning requires a nuanced approach involving both pediatric and arthroplasty orthopaedic considerations. Complication rates of endoprostheses are high and include infection, aseptic loosening, and those specific to certain anatomic locations. Future research should focus on standardized methods of outcome assessment, including patient-reported outcomes, to allow careful comparison across surgical techniques. Progress with regard to implant durability, complication reduction, and enhanced adjuvant therapies are the next steps in optimizing both survival and quality of life in this vulnerable population.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.